SCM
SLDB icon

Silverarc Capital Management’s Solid Biosciences SLDB Stock Holding History

Silverarc Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-452,239
Closed -$1.67M – 84
2025
Q1 		$1.67M Buy
+452,239
New +$1.94M 0.35% 52
2024
Q4 		– Sell
-457,739
Closed -$3.19M – 80
2024
Q3 		$3.19M Sell
457,739
-15,256
-3% -$124K 0.72% 39
2024
Q2 		$2.68M Sell
472,995
-852,070
-64% -$7.63M 0.66% 41
2024
Q1 		$17.6M Buy
1,325,065
+730,210
+123% +$6.83M 4.95% 2
2023
Q4 		$3.65M Buy
+594,855
New +$1.9M 1.13% 35

Other funds holding SLDB

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return